Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott D Crouser

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
ERJ Open Research|January 15, 2025
Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosisOgugua Ndili Obi, Robert P Baughman, Elliott D Crouser, et al.
Chest|June 20, 2017
Improved Early Detection of Sepsis in the ED With a Novel Monocyte Distribution Width BiomarkerElliott D Crouser, Joseph E Parrillo, Christopher Seymour, et al.
BMJ Open|April 29, 2026
Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progressionManeesh Bhargava, Elliott D Crouser, Briana Q Barkes, et al.
American Journal of Respiratory and Critical Care Medicine|February 17, 2009
Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosisElliott D Crouser, Daniel A Culver, Kenneth S Knox, et al.
Respiratory Research|December 5, 2020
Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomasNancy G Casanova, Manuel L Gonzalez-Garay, Belinda Sun, et al.
Chest|January 2, 2021
Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary SarcoidosisWonder P Drake, Daniel A Culver, Robert P Baughman, et al.
Clinical and Experimental Rheumatology|November 17, 2023
Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitisSarah P Cohen, Andrew J Wodarcyk, Alexander Wong, et al.
Clinical Immunology (Orlando, Fla.)|May 26, 2009
Hypothesis: sarcoidosis is a STAT1-mediated diseaseJames T Rosenbaum, Sirichai Pasadhika, Elliott D Crouser, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Critical Care Medicine|May 21, 2019
Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department PatientsElliott D Crouser, Joseph E Parrillo, Christopher W Seymour, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
ERJ Open Research|January 15, 2025
Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosisOgugua Ndili Obi, Robert P Baughman, Elliott D Crouser, et al.
Chest|June 20, 2017
Improved Early Detection of Sepsis in the ED With a Novel Monocyte Distribution Width BiomarkerElliott D Crouser, Joseph E Parrillo, Christopher Seymour, et al.
BMJ Open|April 29, 2026
Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progressionManeesh Bhargava, Elliott D Crouser, Briana Q Barkes, et al.
American Journal of Respiratory and Critical Care Medicine|February 17, 2009
Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosisElliott D Crouser, Daniel A Culver, Kenneth S Knox, et al.
Respiratory Research|December 5, 2020
Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomasNancy G Casanova, Manuel L Gonzalez-Garay, Belinda Sun, et al.
Chest|January 2, 2021
Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary SarcoidosisWonder P Drake, Daniel A Culver, Robert P Baughman, et al.
Clinical and Experimental Rheumatology|November 17, 2023
Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitisSarah P Cohen, Andrew J Wodarcyk, Alexander Wong, et al.
Clinical Immunology (Orlando, Fla.)|May 26, 2009
Hypothesis: sarcoidosis is a STAT1-mediated diseaseJames T Rosenbaum, Sirichai Pasadhika, Elliott D Crouser, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Critical Care Medicine|May 21, 2019
Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department PatientsElliott D Crouser, Joseph E Parrillo, Christopher W Seymour, et al.
Pageof 8